Tecan has launched the Frida Reader™ for the Fluent^® Automation Workstation, offering researchers the ability to quantify nucleic acids without sample loss.

This unique solution performs UV absorbance-based quantification and purity assessment in a hanging drop, avoiding the consumption of rare and precious samples following nucleic acid purification (NAP). This latest offering further expands Tecan’s portfolio of workflow automation solutions and reagents to cover all your genomics needs.

Efficient NAP is crucial prior to applications such as NGS or PCR/qPCR, but laboratories working with low volume, high value samples cannot always afford to lose a portion of their samples for quantification and purity assessment. This can lead to downstream failures if insufficient genetic material is available for processing, or if samples are contaminated with excess protein or salts, wasting time and causing unnecessary consumption of expensive reagents. The Frida Reader eliminates this issue by allowing assessment of sample quality and quantity without any sample loss, aspirating the sample back into the pipette tip after performing hanging drop absorbance measurements. It uses four separate wavelengths – 230, 260, 280 and 320 nm – to allow real-time nucleic acid quantification in the 5 to 1,000 ng/μl range, as well as QC measurements to identify protein contamination. Designed to work in combination with the Fluent platform’s Air Flexible Channel Arm™, this system only occupies a single SLAS-format position on the Dynamic Deck™, and is compatible with both benchtop and cabinet-based instrument configurations, offering flexible integration for labs looking to eliminate sample loss for quantification and QC from their workflow.  

Learn more about Tecan’s Frida Reader

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2019, Tecan generated sales of CHF 637 million (USD 643 million; EUR 574 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

more news from Tecan